Aptevo Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -49 | -61 | -71 | -54 |
EBITDA | -6,177 | -6,480 | -6,311 | -5,129 |
EBIT | -6,226 | -6,541 | -6,382 | -5,213 |
Net Income | -6,204 | -6,408 | -6,312 | -5,101 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,093 | -6,575 | -5,759 | -5,222 |
Cash | 9,410 | 2,139 | 8,714 | 7,753 |
Basic Shares | 738 | 72 | 72 | 14 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,114 | $12,292 |
Gross Profit | -352 | -567 | -14,768 | 12,292 |
EBITDA | -23,778 | -28,311 | -27,740 | -20,256 |
EBIT | -24,130 | -28,878 | -28,641 | -21,400 |
Net Income | -24,130 | -17,411 | 8,027 | -27,313 |
Net Change In Cash | 0 | 0 | 3,114 | 12,292 |
Free Cash Flow | -23,785 | -11,730 | -21,051 | -22,392 |
Cash | 8,714 | 16,904 | 22,635 | 45,044 |
Basic Shares | 13 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$8.40 |
2025-03-31 | -$87.80 |
2024-12-31 | -$178.80 |
2024-09-30 | -$355.20 |
